Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Li

Showing results (1-10 of 161) with videos related to

Pageof 17
Sort By:
The Annals of Applied Statistics|February 16, 2026
INTEGRATIVE ECOLOGICAL REGRESSION ANALYSIS OF U.S. COUNTY AND STATE LEVEL COVID-19 DEATH DATA FOR STUDYING HEALTH DISPARITY ASSOCIATIONSDaniel Li, Xihong Lin
Pharmaceutical Statistics|June 9, 2018
SPIRIT: A seamless phase I/II randomized design for immunotherapy trialsBeibei Guo, Daniel Li, Ying Yuan
Journal of Biopharmaceutical Statistics|February 13, 2019
R-TPI: rolling toxicity probability interval design to shorten the duration and maintain safety of phase I trialsWentian Guo, Yuan Ji, Daniel Li
Genome Biology and Evolution|April 27, 2026
Trans-phylum single cell orthology reveals conserved ovarian cell states between sea urchin and humanDaniel Li, Nathalie Oulhen, Gary M Wessel
Psychiatry and Clinical Psychopharmacology|May 20, 2024
Hikikomori: A Society-Bound Syndrome of Severe Social WithdrawalBin Dong, Daniel Li, Glen B Baker
Facial Plastic Surgery Clinics of North America|November 7, 2025
Understanding The Forehead Through The Endo-Coronal Forehead LiftBrandon Kamrava, Daniel Li, Neil A Gordon
Contraception|January 17, 2015
Benchmark pregnancy rates and the assessment of post-coital contraceptives: an updateDaniel Li, Allen J Wilcox, David B Dunson
Contemporary Clinical Trials Communications|December 5, 2019
2D (2 Dimensional) TEQR design for Determining the optimal Dose for safety and efficacyRevathi Ananthakrishnan, Stephanie Green, Daniel Li, et al.
General Hospital Psychiatry|January 12, 2021
COVID-19 pandemic inpatient bed allocation planning - A Canada-wide approachAntonio Paletta, Dorothy Yu, Daniel Li, et al.
Contemporary Clinical Trials Communications|April 27, 2018
Extensions of the mTPI and TEQR designs to include non-monotone efficacy in addition to toxicity for optimal dose determination for early phase immunotherapy oncology trialsRevathi Ananthakrishnan, Stephanie Green, Daniel Li, et al.
Pageof 17

Showing results (1-10 of 161) with videos related to

Sort By:
Pageof 17
The Annals of Applied Statistics|February 16, 2026
INTEGRATIVE ECOLOGICAL REGRESSION ANALYSIS OF U.S. COUNTY AND STATE LEVEL COVID-19 DEATH DATA FOR STUDYING HEALTH DISPARITY ASSOCIATIONSDaniel Li, Xihong Lin
Pharmaceutical Statistics|June 9, 2018
SPIRIT: A seamless phase I/II randomized design for immunotherapy trialsBeibei Guo, Daniel Li, Ying Yuan
Journal of Biopharmaceutical Statistics|February 13, 2019
R-TPI: rolling toxicity probability interval design to shorten the duration and maintain safety of phase I trialsWentian Guo, Yuan Ji, Daniel Li
Genome Biology and Evolution|April 27, 2026
Trans-phylum single cell orthology reveals conserved ovarian cell states between sea urchin and humanDaniel Li, Nathalie Oulhen, Gary M Wessel
Psychiatry and Clinical Psychopharmacology|May 20, 2024
Hikikomori: A Society-Bound Syndrome of Severe Social WithdrawalBin Dong, Daniel Li, Glen B Baker
Facial Plastic Surgery Clinics of North America|November 7, 2025
Understanding The Forehead Through The Endo-Coronal Forehead LiftBrandon Kamrava, Daniel Li, Neil A Gordon
Contraception|January 17, 2015
Benchmark pregnancy rates and the assessment of post-coital contraceptives: an updateDaniel Li, Allen J Wilcox, David B Dunson
Contemporary Clinical Trials Communications|December 5, 2019
2D (2 Dimensional) TEQR design for Determining the optimal Dose for safety and efficacyRevathi Ananthakrishnan, Stephanie Green, Daniel Li, et al.
General Hospital Psychiatry|January 12, 2021
COVID-19 pandemic inpatient bed allocation planning - A Canada-wide approachAntonio Paletta, Dorothy Yu, Daniel Li, et al.
Contemporary Clinical Trials Communications|April 27, 2018
Extensions of the mTPI and TEQR designs to include non-monotone efficacy in addition to toxicity for optimal dose determination for early phase immunotherapy oncology trialsRevathi Ananthakrishnan, Stephanie Green, Daniel Li, et al.
Pageof 17